CompletedNot Applicable

Dexamethasone Versus Prednisolone in Acute Exacerbation of Childhood Asthma

Pakistan224 participantsStarted 2024-11-03

Plain-language summary

Because of insufficient local comparative data, this study was designed to determine the outcome of intravenous dexamethasone in contrast to oral prednisolone in acute exacerbation of asthmatic children.

Who can participate

Age range2 Years – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children of any gender * Aged 2-12 years * Presenting with acute exacerbation of asthma within 24-hours Exclusion Criteria: * Children with PRAM score of ≥ 10 * Used oral or parenteral corticosteroids in last 4-weeks * With any chronic condition of lungs (TB, cystic fibrosis), liver (chronic liver disease), kidneys (chronic kidney disease, nephrotic syndrome) or blood (thalassemia, malignancy)

What they're measuring

Asthma exacerbation

Timeframe: 4 days

Trial details

NCT IDNCT07275593

SponsorMuhammad Aamir Latif

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04-03

View on ClinicalTrials.gov More Acute Exacerbation of Asthma trials